Comment by
Noteable on May 18, 2024 12:06pm
Should read: " ... by "priming" the immune system and remodeling the TME in advance of the addition anti-PD-(L)1 antibody treatment, pelareorep is able to synergistically combine with immune checkpoint inhibitors (ICI) ... making ONCY's pelareorep a critical facilitator to any proposed ADC / ICI combination,..."
Comment by
Noteable on Jun 03, 2024 10:03am
https://stockhouse.com/companies/bullboard/t.onc/oncolytics-biotech-inc?postid=36068616
Comment by
Noteable on Jun 03, 2024 10:11am
https://www.nasdaq.com/press-release/emerging-trends-in-oncology:-asco-2024-highlights-next-gen-antibody-drug-conjugates
Comment by
Noteable on Jun 03, 2024 10:45am
Should read: " ONCY's pelareorep stimulates the immune system.through the enhancement of new and existing TiLs ..."
Comment by
Noteable on Jun 03, 2024 10:58am
Shouls read : " .. enabling the transformation of a "cold tumor" into a "hot tumor" and remodels the TME for the synergistic addition of immune checkpoint inhibitors ..."
Comment by
Azzak34 on Jun 03, 2024 2:01pm
https://www.fiercebiotech.com/biotech/pharma-awaits-fed-relief-1t-firepower-spend-biotech-innovation-report
Comment by
Noteable on May 19, 2024 3:51pm
In the difficult context of all the highlighted issues with ADCs, Pfizer still acquired the ADC company Seagen for US$43 Billion last year, and will be seeking solutions to the issues discussed on this message board, through its continuing M&A activites.
Comment by
Noteable on May 20, 2024 3:17pm
And Seagen was founded in 1998 and acquired by Pfizer for US$ 43 Billion last year